HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Featured

New Bills Propose High Taxes for Unjustified Drug Price Increases

Legislators in Washington and Hawaii have introduced bills aimed at drug price increases by pharmaceutical companies. Should these bills be passed, price increases without sufficient clinical evidence would bring large penalties upon the pharma companies. These bills, among others aimed at limiting […]

more info 03/02/2021View Related Articles
Bookmark and Share

Aetna Return to ACA Exchanges Reflects Industry-Wide Trend Amid COVID-19 Relief Package Boost

The Aetna insurance division of the CVS Health Corp. will return to the ACA (Affordable Care Act) exchanges in 2022. Experts see the move as a sign that the individual insurance market is becoming increasingly appealing for payers. This Aetna move is expected to be one of many similar shifts in the […]

more info 03/02/2021View Related Articles
Bookmark and Share

A Discussion with Paul Perreault of CSL Limited on COVID-19

Paul Perreault is CEO and Managing Director of CSL Limited, a top three global biotech company. He was invited to share his insights regarding COVID-19 and how his company has been able to adjust to the pandemic. CSL helped to establish the CoVIg-19 Plasma Alliance to develop immune therapies and […]

more info 03/01/2021View Related Articles
Bookmark and Share

Will ‘All of Us’ Bring Positive Change to Research?

“All of Us” is the $1.5 billion initiative led by the federal government with the purpose of collecting health data from diverse backgrounds. It’s considered as an important step forward in precision medicine—for all backgrounds. At the same time, it may also have far-reaching impacts in driving […]

more info 03/01/2021View Related Articles
Bookmark and Share

Google Reveals Care Studio Tool for Providers

Google has piloted a new search tool for electronic medical records called Care Studio. In the trial phase, around 250 clinicians will be able to use it. The tool will allow providers to save time when sorting through patient records. Over a year ago, Google attempted a partnership with the hospital […]

more info 03/01/2021View Related Articles
Bookmark and Share

IBM’s Watson AI Technology Falls Short of Potential

A decade ago, IBM (International Business Machine Corporation) used its AI (artificial intelligence) technology system termed Watson to beat people in the show “Jeopardy!” This showcase led to much speculation on the use of AI in other sectors, especially healthcare. Now, IBM is considering selling […]

more info 03/01/2021View Related Articles
Bookmark and Share

NBER Releases Cost-Sharing Report: Drug Price Increases Associated With Increased Mortality

The National Bureau of Economic Research (NBER) has released a report on how cost-sharing affects patient care. The authors found that a price increase of approximately $10.40 per drug leads to a 22.6 % decrease in use of prescription drugs. The price increase also corresponds to a significant […]

more info 03/01/2021View Related Articles
Bookmark and Share

Datavant Seeks to Improve Data Sharing

Datavant seeks to streamline data sharing across platforms while maintaining privacy. Datavant has recently announced partnerships with specialty hub providers, including IntegriChain, PRECISIONxtract, and EVERSANA. Unlike other platforms, Datavant provides extensive patient data, without disclosing […]

more info 02/26/2021View Related Articles
Bookmark and Share

Epidemiologists Build COVID-19 Data Platform—With Help From Google
   Epidemiologists Build COVID-19 Data Platform—With Help From Google

In January of 2020, Samuel Scarpino, director of the Emergent Epidemics Lab at Northeastern University, started inputting data in a globally-shared worksheet. This worksheet was the basis for a new website: Global.health. Anonymized records of five million COVID-19 cases from more than 100 countries […]

more info 02/26/2021View Related Articles
Bookmark and Share

CDC Introduces VaccineFinder

In an effort to provide the public with information regarding COVID-19 vaccine availability, the CDC has released VaccineFinder, an online tool that allows users to find a COVID-19 vaccine close to their zip code. Users can select either the Moderna or Pfizer-BioNTech vaccine, check availability, […]

more info 02/26/2021View Related Articles
Bookmark and Share

Republicans Criticize Biden’s Health Secretary Pick

Biden’s pick for health secretary, Xavier Becerra, currently serving as attorney general in California, has not been welcomed by Republican Senators. The main criticism centers around his stance on pharma: Becerra isn’t supportive enough. “The attack on Xavier Becerra, California’s attorney […]

more info 02/26/2021View Related Articles
Bookmark and Share

Aetion Vice President of Growth and Strategic Partnerships Discusses RWE

Ian Rentsch recently became Vice President of Growth and Strategic Partnerships at Aetion. He previously held roles in clinical research and development and in global RWD (real world data) companies. In a recent discussion, he offers his opinions regarding the state of RWE (real world evidence) and […]

more info 02/26/2021View Related Articles
Bookmark and Share

[Workshop] RWE in Regulatory Decision-Making Processes

A recent workshop focusing on RWE (real world evidence) explored the role in observational studies in determining drug effectiveness and in seeking FDA approval. Speakers discuss challenges in using RWE and how to identify and address gaps in knowledge. The two-day online workshop took place in […]

more info 02/25/2021View Related Articles
Bookmark and Share

[Webinar] RWE in Drug Development

Dr. Nicolle Gatto of Aetion, along with leaders from Sanofi and Janssen, will discuss the use of RWE (real world evidence) by their companies in a webinar hosted by Maire Gerrard of Informa Pharma Intelligence. The webinar will take place on March 10th at 10 AM ET. The invitees will discuss […]

more info 02/25/2021View Related Articles
Bookmark and Share

Understanding the Impact of COVID-19 on SDoH

COVID-19 has wreaked havoc across countless sectors and populations and has also deepened the social determinant risk. A new eBook explores food insecurity, barriers to education, and inequities in nursing homes. It also discusses attempts at correcting these factors by the government and the […]

more info 02/25/2021View Related Articles
Bookmark and Share

Panalgo Releases RWD Benchmarking Report

Healthcare analytics company Panalgo released its 2021 State of Healthcare Analytics Benchmarking Report, featuring insight into the use of RWD (real world data). The report was based on an in-depth survey on how life sciences companies utilize RWD by Fierce Pharma. The authors also discuss barriers […]

more info 02/25/2021View Related Articles
Bookmark and Share

Icon Acquires PRA Health Sciences for $12 Billion

The use of decentralized trials has surged during COVID-19. CRO (contract research organization) Icon is set to acquire PRA Health Sciences. This will bring big changes to CROs and Icon is expected to direct anincreasing number of decentralized trials. “Icon, the Dublin-based CRO, will acquire […]

more info 02/25/2021View Related Articles
Bookmark and Share

Reference Pricing Could Negatively Affect Vulnerable Populations

Some countries use QALYs (Quality-Adjusted Life Years) to assess whether or not to use a treatment or prescription drug. The authors note this approach would bring negative consequences for people with chronic illness, people with disabilities, and older individuals in the United […]

more info 02/24/2021View Related Articles
Bookmark and Share

Webinar on Providing Meaningful Price Transparency Information

In order to comply with recent rulings, many organizations are sharing large amounts of data. However, not all data is necessary or even desired. Join this webinar to hear more about what consumers want to know—and what they don’t. Alison Greco of HealthSparq will share her insights. The webinar […]

more info 02/24/2021View Related Articles
Bookmark and Share

Using RWE to Make Cost Decisions: A New Report

A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world evidence) can be utilized when making economic decisions. ICER (the Institute for Clinical and Economic Review) has incorporated RWE in making its recommendations, but few other […]

more info 02/24/2021View Related Articles
Bookmark and Share

Payer Engagement Summit Videos on RWD Now Available

ISPOR held its first Payer Engagement Summit in 2020 to discuss the issues facing payers worldwide. The Summit featured discussions regarding the use of RWD (real world data). Payers face unique challenges when considering the use of RWD. Invited speakers included Fran Cunningham of the US […]

more info 02/24/2021View Related Articles
Bookmark and Share

COVID-19 CARE Registry Provides Informative Data

Dr. Nancy Dreyer is the Chief Scientific Officer of IQVIA Real World Solutions. In a recent interview led by Dr. Patti Peeples, CEO of HealthEconomics.Com and Vice President of Evidence and Content at Scientist.com, the scientists discussed how IQVIA has taken on COVID-19. The CARE (COVID Active […]

more info 02/24/2021View Related Articles
Bookmark and Share

Syapse Invests $68 Million in Expanding RWE to Improve Outcomes for Cancer Patients

Leading RWE (real world evidence) company Syapse has invested $68 million in a venture with Ally Bridge Group and Northpond Ventures. Syapse will expand its Learning Health Network. The overall goal is to improve outcomes for oncology patients. Additional goals are to reduce costs and to enhance […]

more info 02/23/2021View Related Articles
Bookmark and Share

Telehealth Brings Change to Traditional Clinical Visit—and Billing

The start of the COVID-19 pandemic brought many changes to the conventional doctor’s visit. A report by McKinsey found that telehealth adoption rose from 11% to now 46%. Healthcare providers are seeing between 50 and 175 times the patients via telehealth. Continuous remote patient monitoring makes […]

more info 02/23/2021View Related Articles
Bookmark and Share

What Does the FDA Think About RWE?

A year into the COVID-19 pandemic, the use of RWE in clinical study design is becoming more widespread. In a recent informative dialogue, Dr. Nancy Dreyer of IQVIA spoke with Dr. Amy Abernethy of the FDA regarding the different types of data included under the RWE umbrella. Dr. Abernethy provides […]

more info 02/23/2021View Related Articles
Bookmark and Share

As Pandemic Slows, Will Pfizer Increase Vaccine Price?

Pfizer is charging the United States $19.50 per dose of its new vaccine to prevent COVID-19. Pfizer CFO Frank D’Amelio considers this “pandemic pricing.” He notes that a typical price for a vaccine produced by Pfizer is around $150 to $175. He expects the price for Pfizer’s COVID-19 vaccine to rise […]

more info 02/23/2021View Related Articles
Bookmark and Share

Upcoming Webinar on COVID-19 Therapeutics and Vaccines

An upcoming webinar will review the data behind treatments for COVID-19, as well as vaccines that have received FDA emergency use approval. There are currently several treatments that are being evaluated by the FDA. This will be an informative event for many audiences, especially pharmacists in […]

more info 02/23/2021View Related Articles
Bookmark and Share

Good News: RWE Shows Effectiveness of COVID-19 Vaccines

A recent study examines how the vaccines produced by Moderna and Pfizer might protect against COVID-19. RWE (real world evidence) shows that these vaccines are broadly effective—both in preventing infection and reducing incidence of serious disease. The Pfizer vaccine is 95% effective and the […]

more info 02/22/2021View Related Articles
Bookmark and Share

Importing Prescription Drugs: What Does Biden Think?

According to former President Trump and current President Biden, Americans should be able to buy prescription drugs from other countries. Despite Biden’s assurances, skepticism remains high. Florida attempted to implement a prescription drug importation program, but faced serious issues. A $30 […]

more info 02/22/2021View Related Articles
Bookmark and Share

A Conversation With Ge Bai Regarding Amazon’s Pharmacy Foray

In a recent podcast with Dr. Ge Bai of Johns Hopkins, important points are discussed relating to Amazon’s venture into the pharmacy space. Her extensive background in in public health and business make for an informative discussion. She discusses PBMs (pharmacy benefit managers) and the reasons […]

more info 02/22/2021View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 121
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Artificial Intelligence Can Boost Reliability and Speed of Medical Imaging Analysis in Clinical Trials
  • Health Technology Assessment in the U.S. – A Vision for the Future
  • Follow the Dollar Part II
  • 3 Steps for Building your SDOH Business Case
  • New Paths in Predictive Payer Coverage: Insights drawing from historical metrics that optimize pre- and post-commercialization marketing efforts for new therapies
  • 2021 Medication Access Report
  • Navigating forward: Whole-person care for better health
  • Navigating forward: A look back and look forward
  • Transforming Healthcare with Automated Machine Learning
  • The Gene Therapy Transformation: A Guide for Managed Care Decision Makers Web Activity
  • How to Mitigate Revenue Cycle Risk During an EHR Implementation
  • Case Study: Bending the Cost Trend for Medicare Advantage Members
  • Responding to COVID-19 with Data: Success Stories
  • How Successful Organizations are Addressing Cost Issues with Data
  • Addressing Revenue Challenges Using Data: Success Stories
  • Data-informed Care Transformation: Five Success Stories
  • Next-Generation Value-Based Payment Strategies
  • 2021 Outlook: Five Themes That Will Define Co-Pay Assistance
  • Take your market access to the next level: your free digital transformation eBook
  • How Healthy Are Your Market Access Programs? A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • Data removes the barriers to understanding rare disease
  • The Future Was Today
  • How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
  • Strategies for Engaging Vulnerable Populations in Healthcare
  • Tracing the health care experience informs decision-making
  • Driving More Value and Cost Savings With SDOH Data
  • Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols
  • Transformation of Clinical Trial Design and Operations
  • Using real-world data to close the rare disease data gap
  • Analysis and Insights from Real-World Clinical Registries: RA, GCA, JIA, & SLE

Syndicated Reports

  • Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry
  • Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights
  • Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19
  • Health Economics & Outcomes Research (HEOR) Services Market to 2027
  • Healthcare Artificial Intelligence Market by Product and Services – Global Forecast to 2027
  • Bioinformatics Market – Growth, Share, Opportunities & Competitive Analysis, 2020 – 2028
  • Big Data and AI in Market Access
  • Altruista Health Payer Index Survey 2020 Report
  • Innovations in Drug Pricing and Reimbursement 2020
  • Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
  • Real World Data for Orphan Drugs: Meeting the Data Analysis Challenge
  • Directory of Health Plans: Trusted Health Insurance Plan Enrollment and Affiliation Data
  • Global Value-Based Reimbursement Software Market Report
  • Health Economics & Outcomes Research (HEOR) Services Market: Emerging industries, Challenges and Threats Faced by Key Vendors(Axtria, Avalon Health Economics, Cardinal Health, ICON, IQVIA, McKesson, MEDLIOR, Optum, PharmaLex, (PPD), RTI)
  • World Preview 2019, Outlook to 2024
  • Provider Perceptions of Value-Based Care
  • Healthcare Industry’s Response to COVID-19
  • Value-Based Care Assessment
  • Pharmacy Benefit Management Market in US – Industry Outlook and Forecast 2020-2025
  • 2025 Growth: Healthcare Reimbursement Market set to grow with massive rate by 2020 to 2025
  • Global Specialty Pharmaceutical Market 2020- Pfizer, Roche, Amgen, AbbVie
  • 3 Trends to Accelerate Time to Market
  • Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery
  • Engaging with ICER: Lessons and insights for pharma
  • COVID-19 Implications for pharma: US payer insights
  • Pricing and Reimbursement in Oncology
  • Digital Technologies: New Strategies for Customer Engagement
  • Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024
  • 2019 Healthcare Benchmarks: Social Determinants of Health
  • Pricing Transparency in Pharma
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute